Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Zinc Supplementation Prior to Botulinum Neurotoxin Type A Injection in the Treatment of Spasmodic Dysphonia

NCT05892770 is registered in ClinicalTrials.gov with University of Florida as lead sponsor.

NCT NCT05892770
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05892770 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Zinc Supplementation Prior to Botulinum Neurotoxin Type A Injection in the Treatment of Spasmodic Dysphonia
Lead sponsor
University of Florida
Phase
Phase 1/2
Overall status
Completed
Start date
August 1, 2023
Completion date
March 1, 2025
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

spasmodic dysphonia